BackMillennium Cell Overview

Millennium Cell EBIT

Millennium Cell's EBIT is $-10M, above the sector sector average of $-22M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.55M
17.04% YoY

As of Dec 31, 2007

Annual EBIT (TTM)

-$10.42M
11.74% YoY

Trailing 12 months ending Dec 31, 2007

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Millennium Cell (MCELQ) FAQ

The latest EBIT for MCELQ is $-10M as of December 2007. That compares with $-12M in the prior-year period — up 11.7% year over year. That is above the sector sector average of $-22M. Investors often review this figure alongside Millennium Cell's historical trend and sector peers before judging valuation or financial health.

Over the past year, MCELQ's EBIT moved from $-12M to $-10M — a 11.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Millennium Cell's operating scale or balance-sheet position.

Against its sector companies, MCELQ currently prints $-10M for EBIT, while the sector average sits near $-22M. That is roughly 51.6% above the sector mean. Large gaps often invite a closer look at Millennium Cell's growth, margins, and balance sheet.

A EBIT figure of $-10M for MCELQ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-22M. Explore the charts below for those layers of context.

After noting MCELQ's EBIT ($-10M), review year-over-year change from $-12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.